LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Pulmonary thrombosis in Covid-19: before, during and after hospital admission.

    Vlachou, Maria / Drebes, Anja / Candilio, Luciano / Weeraman, Deshan / Mir, Naheed / Murch, Nick / Davies, Neil / Coghlan, J Gerry

    Journal of thrombosis and thrombolysis

    2021  Volume 51, Issue 4, Page(s) 978–984

    Abstract: ... in association with Covid-19. Also, the thrombotic risk in the pulmonary vasculature is present before and during ... in coronavirus disease 2019 (Covid-19). We evaluated the prevalence of pulmonary thrombosis and reported RV ... from Covid-19. Finally, we observed a case of RV dysfunction and pre-capillary pulmonary ...

    Abstract Disordered coagulation, endothelial dysfunction, dehydration and immobility contribute to a substantially elevated risk of deep venous thrombosis, pulmonary embolism (PE) and systemic thrombosis in coronavirus disease 2019 (Covid-19). We evaluated the prevalence of pulmonary thrombosis and reported RV (right ventricular) dilatation/dysfunction associated with Covid-19 in a tertiary referral Covid-19 centre. Of 370 patients, positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), 39 patients (mean age 62.3 ± 15 years, 56% male) underwent computed tomography pulmonary angiography (CTPA), due to increasing oxygen requirements or refractory hypoxia, not improving on oxygen, very elevated D-dimer or tachycardia disproportionate to clinical condition. Thrombosis in the pulmonary vasculature was found in 18 (46.2%) patients. However, pulmonary thrombosis did not predict survival (46.2% survivors vs 41.7% non-survivors, p = 0.796), but RV dilatation was less frequent among survivors (11.5% survivors vs 58.3% non-survivors, p = 0.002). Over the following month, we observed four Covid-19 patients, who were admitted with high and intermediate-high risk PE, and we treated them with UACTD (ultrasound-assisted catheter-directed thrombolysis), and four further patients, who were admitted with PE up to 4 weeks after recovery from Covid-19. Finally, we observed a case of RV dysfunction and pre-capillary pulmonary hypertension, associated with Covid-19 extensive lung disease. We demonstrated that pulmonary thrombosis is common in association with Covid-19. Also, the thrombotic risk in the pulmonary vasculature is present before and during hospital admission, and continues at least up to four weeks after discharge, and we present UACTD for high and intermediate-high risk PE management in Covid-19 patients.
    MeSH term(s) COVID-19/blood ; COVID-19/complications ; COVID-19/mortality ; COVID-19/therapy ; Computed Tomography Angiography/methods ; Female ; Fibrin Fibrinogen Degradation Products/analysis ; Heart Ventricles/diagnostic imaging ; Heart Ventricles/pathology ; Humans ; Hypoxia/etiology ; Hypoxia/therapy ; Male ; Middle Aged ; Organ Size ; Outcome and Process Assessment, Health Care ; Pulmonary Embolism/diagnostic imaging ; Pulmonary Embolism/etiology ; Pulmonary Embolism/physiopathology ; Risk Assessment ; Risk Factors ; SARS-CoV-2 ; Thrombolytic Therapy/methods ; Ultrasonography, Interventional/methods ; United Kingdom ; Ventricular Dysfunction, Right/diagnosis ; Ventricular Dysfunction, Right/etiology ; Ventricular Dysfunction, Right/physiopathology
    Chemical Substances Fibrin Fibrinogen Degradation Products ; fibrin fragment D
    Language English
    Publishing date 2021-01-01
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1230645-9
    ISSN 1573-742X ; 0929-5305
    ISSN (online) 1573-742X
    ISSN 0929-5305
    DOI 10.1007/s11239-020-02370-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Occurrence of pulmonary embolism related to COVID-19.

    Hauguel-Moreau, Marie / Hajjam, Mostafa El / De Baynast, Quentin / Vieillard-Baron, Antoine / Lot, Anne-Sophie / Chinet, Thierry / Mustafic, Hazrije / Bégué, Céline / Carlier, Robert Yves / Geri, Guillaume / Dubourg, Olivier / Beaune, Sébastien / Mansencal, Nicolas

    Journal of thrombosis and thrombolysis

    2020  Volume 52, Issue 1, Page(s) 69–75

    Abstract: ... We recorded the global number of hospitalizations during the COVID-19 pandemic and during the same period ... During the COVID-19 outbreak, a 97.4% increase of PE incidence was observed as compared to 2017-2019 and ... in-hospital mortality (14% versus 3.4%, p=0.04). Among COVID-19 patients, diagnosis of PE was performed at admission ...

    Abstract Recent reports have suggested an increased risk of pulmonary embolism (PE) related to COVID-19. The aim of this cohort study is to compare the incidence of PE during a 3-year period and to assess the characteristics of PE in COVID-19. We studied consecutive patients presenting with PE (January 2017-April 2020). Clinical presentation, computed tomography (CT) and biological markers were systematically assessed. We recorded the global number of hospitalizations during the COVID-19 pandemic and during the same period in 2018-2019. We included 347 patients: 326 without COVID-19 and 21 with COVID-19. Patients with COVID-19 experienced more likely dyspnea (p=0.04), had lower arterial oxygen saturation (p<0.001), higher C-reactive protein and white blood cell (WBC) count (p<0.0001 and p=0.001, respectively), and a significantly higher in-hospital mortality (14% versus 3.4%, p=0.04). Among COVID-19 patients, diagnosis of PE was performed at admission in 38% (n=8). COVID-19 patients with diagnosis of PE during hospitalization (n=13) had significantly more dyspnea (p=0.04), lower arterial oxygen saturation (p=0.01), less proximal PE (p=0.02), and higher heart rate (p=0.009), CT severity score (p=0.001), C-reactive protein (p=0.006) and WBC count (p=0.04). During the COVID-19 outbreak, a 97.4% increase of PE incidence was observed as compared to 2017-2019 and the proportion of hospitalizations related to PE was 3.7% versus 1.3% in 2018-2019 (p<0.0001). In conclusion, the COVID-19 pandemic leads to a dramatic increased incidence of PE. Physicians should be aware that PE may be diagnosed at admission, but also after several days of hospitalization, with a different clinical, CT and biological features of thrombotic disease.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; COVID-19/diagnosis ; COVID-19/epidemiology ; COVID-19/mortality ; COVID-19/therapy ; Female ; France/epidemiology ; Hospital Mortality ; Humans ; Incidence ; Male ; Middle Aged ; Patient Admission ; Prognosis ; Pulmonary Embolism/diagnosis ; Pulmonary Embolism/epidemiology ; Pulmonary Embolism/mortality ; Pulmonary Embolism/therapy ; Risk Assessment ; Risk Factors ; Time Factors
    Keywords covid19
    Language English
    Publishing date 2020-10-06
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1230645-9
    ISSN 1573-742X ; 0929-5305
    ISSN (online) 1573-742X
    ISSN 0929-5305
    DOI 10.1007/s11239-020-02292-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top